Skip to main content

Table 1 Summary of signalment, clinical data and evolution for veterinary patients

From: Safety and efficacy of the mesenchymal stem cell in feline eosinophilic keratitis treatment

Parameter Cat-1 Cat-2 Cat-3 Cat-4 Cat-5
Age (years) 4 4 5 6 3
Sex MC MC MC FS FS
Breed DSH DSH DSH DSH DSH
Weight (kg) 3.2 3.8 3.8 4 4.1
Duration (months) 12 9 8 10 6
Eye R L L R R
Lesion localization ST ST IN IN ST
FHV-1 + + + +
Clinical signs PL,V, H PL, V, ED, H PL, V, ED, H PL, V, H PL, V, H
STT 14 18 16 21 19
Cytology E, M E, M E, M, N E, M E, M
Previous treatment C, Ca, Ao Ca, Ly, Ao Ca, C, Ly, Ao Ca, C, Ly, IΩ, Ao Ca, Ly, IΩ, Mg, Ao
Clinical remission 2 months 2 months 6 months 4 months 5 months
Hematologic changes No No No No No
  1. MC, male castrated; FS, female spayed; DSH, domestic short hair; R, right eye; L, left eye; ST, superotemporal quadrant; IN, inferonasal quadrant; FHV-1, feline herpes virus 1; PL, corneal infiltrative plaque; V, vascularization; H, hyperemia; ED, corneal edema; STT, Schirmer tear test; E, eosinophils; M, mast cells; N, neutrophils; C, topical corticosteroids; Ca, topical cyclosporine A; Ao, antibiotics; Ly, L-lysine; IΩ, topical interferon omega; Mg, oral megestrol acetate